Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2025
Reporting Period: Fiscal quarter ended June 30, 2025
Context: The filing serves to announce the issuance of a press release containing financial results for the specified quarter. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. The filing states that revenue, profit, cash flow, margins, debt, and liquidity figures are contained within the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, no specific values can be reported from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended June 30, 2025, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued by the Company on August 14, 2025, but does not include the text of that commentary.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is furnished, not "filed," under Section 18 of the Exchange Act and is not subject to the liabilities of that section unless expressly incorporated by reference in other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended June 30, 2025.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial report.